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Oral vaccination remains a challenge. We observed that oral immunization of piglets 
with F4 fimbriae induces a protective intestinal immune response evidenced by an F4-
specific serum and intestinal IgA response (Van den Broeck et al., 1999) and 
demonstrated that this is due to targeting of aminopeptidase N (APN) on the brush 
border of small intestinal enterocytes (Melkebeek et al., 2012). This results in 
transcytosis of the fimbriae which are subsequently taken up by SIRPα positive cells 
(Snoeck et al., 2008). Dendritic cells differentiate to a semi-mature state, which is 
sufficient to enhance F4 presentation to T-lymphocytes and leads to a robust F4-
specific IgA response (Devriendt et al., 2009). Most piglets have colostral immunity 
against F4 and it had not been determined if targeting APN with F4 fimbriae, could 
overcome this passive immunity. In 3- to 4-week-old piglets without maternal 
antibodies the oral immunization induced F4-specific serum IgG and IgA responses, 
which were not observed in piglets with maternal antibodies. However, ELIspot 
assays revealed F4-specific circulating antibody secreting cell responses. Enriching 
the IgA+ B cell fraction, demonstrated a more robust F4-specific IgA booster in pigs 
with than without maternal antibodies, suggesting that the maternal antibodies 
enhanced the secondary response. Results indicate that in the presence of colostral 
immunity, ELIspot assays on enriched IgA+ B-cells could be used to optimize 
mucosal immunization protocols. 
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